Summary:
To address drug shortages and concerns about quality, industry experts say Congress should consider steps such as improving hospital incentives and revising purchasing contracts.
Mounting drug shortages and supply chain vulnerabilities are putting patient care at risk in hospitals across the nation. As experts sound the alarm in Congress, questions grow about the safety, cost, and reliability of vital medicines. What concrete steps can policymakers and industry leaders take to secure America’s pharmaceutical future? Read on to discover the proposals and debates shaping the path forward.
Source: Senate Committee Examines Ways to Strengthen the Supply Chain for Hospital Drugs, Nick Hut, HFMA, October 13,2025; https://www.hfma.org/operations-management/senate-committee-examines-ways-to-strengthen-the-supply-chain-for-hospital-drugs/ .
Topics
Quality Improvement
Healthcare Process
Environmental Influences
Related
In Your Medical Practice, Is Your “Nice” Quotient Too High?Clinical Characteristics and Discharge Planning for Inpatients Leaving Against Medical Advice — A Retrospective Chart Review“I Felt Violated”: What One Patient Complaint Taught Me About AI in the Exam RoomRecommended Reading
Quality and Risk
In Your Medical Practice, Is Your “Nice” Quotient Too High?
Quality and Risk
Clinical Characteristics and Discharge Planning for Inpatients Leaving Against Medical Advice — A Retrospective Chart Review
Strategy and Innovation
The Reform Nobody's Talking About: Universal Healthcare Without Single Payer
Strategy and Innovation
Where Will Doctors Train? Residency Applications, Abortion Restrictions, and the Coming Workforce Crisis
Strategy and Innovation
A Short History of the Convenience Store: What It Means for Modern Medical Care